SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-051101
Filing Date
2021-10-01
Accepted
2021-10-01 16:08:12
Documents
1
Period of Report
2021-09-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4962
  Complete submission text file 0001213900-21-051101.txt   7530
Mailing Address C/O PROTINE DESIGN LAB 7442 NORTH MARCER WAY MERCER ISLAND WA 98040
Business Address
MCDADE MARK (Reporting) CIK: 0001242126 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211298948

Mailing Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004
Business Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004 (425) 709-0772
Qiming U.S. Healthcare Fund II, L.P. (Reporting) CIK: 0001765710 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211298950

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004 425-709-0772
Qiming U.S. Healthcare GP II, LLC (Reporting) CIK: 0001868862 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211298949